Occurrence of Myoclonus in Patients Treated With Cyclic Antidepressants
- 1 March 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 44 (3) , 269-272
- https://doi.org/10.1001/archpsyc.1987.01800150081010
Abstract
• Myoclonus associated with cyclic antidepressant therapy has been considered to be a rare phenomenon. Ninety-eight patients who were to begin receiving cyclic antidepressant therapy were prospectively evaluated for myoclonus. Thirty patients experienced clinically insignificant drug-associated myoclonus. Nine patients had clinically significant myoclonus. The myoclonus was reversible with the discontinuation of therapy but tended to persist if medication changes were not made. None of the tested clinical variables were able to predict which patients would develop myoclonus.This publication has 17 references indexed in Scilit:
- Subjective Complaints During Desipramine TreatmentArchives of General Psychiatry, 1984
- Myoclonus and ocular oscillations induced by L‐tryptophanAnnals of Neurology, 1982
- Myoclonus-associated hypomania during MAO-inhibitor treatmentAmerican Journal of Psychiatry, 1980
- Tricyclic AntidepressantsNew England Journal of Medicine, 1978
- CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE OXIDASE INHIBITOR, AND CLONAZEPAMBrain, 1977
- Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1977
- Tricyclic-induced myoclonusAmerican Journal of Psychiatry, 1977
- L‐5‐hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominentNeurology, 1976
- An animal behavior model for studying central serotonergic synapsesLife Sciences, 1976
- The role of serotonin in the pathophysiology of myoclonic seizures associated with acute imipramine toxicityNeurology, 1974